Decreased cortisol production in male type I diabetic patients

European Journal of Clinical Investigation

Volumn 33, Issue 7, 2003, Pages 589-594

  Kerstens, M N ^a   Luik, P T ^a   Van Der Kleij, F G H ^a   Boonstra, A H ^a   Breukelman, H ^a   Sluiter, W J ^a   Navis, G J ^a   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

11 hydroxysteroid dehydrogenase; Cortisol; Type 1 diabetes mellitus

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; HYDROCORTISONE; STEROID 5ALPHA REDUCTASE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE RELEASE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; SALT LOADING; SODIUM INTAKE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; MALE; SODIUM CHLORIDE, DIETARY;

EID: 0038127184     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01171.x     Document Type: Article

References (33)

1. Lentle BC, Thomas JP. Adrenal function and the complications of diabetes mellirus. Lancet 1964: 544-9.
2. MacGillivray MH, Voorhess ML, Putnam TI, Li PK, Schaefer PA, Bruck E. Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus. Diabetes Care 1982;5 (Suppl. 1):38-47.
3. Roy MS, Roy A, Gallucci WT, Collier B, Young K, Kamilaris TC et al. The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 1993;42:696-700.
4. Roy MS, Roy A, Brown S. Increased urinary-free cortisol outputs in diabetic patients. J Diabetes Complications 1998;12:24-7.
5. Dacou-Voutetakis C, Peppa-Patrikiou M, Dracopoulou M. Urinary free cortisol and its nyctohemeral variation in adolescents and young adults with IDDM: relation to endothelin 1 and indices of diabetic angiopathy. J Pediatr Endocrinol Metab 1998;11:437-45.
6. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998;83:1806-9.
7. Ehrlich EN. Reciprocal variations in urinary cortisol and aldosterone in response to increased salt intake in humans. J Clin Endocr 1966;26:1160-9.
8. Wambach G, Bleienheuft C, Bonner G. Sodium loading raises urinary cortisol in man. J Endocrinol Invest 1986;9:257-9.
9. Lewicka S, Nowicki M, Vecsei P. Effect of sodium restriction on urinary excretion of cortisol and its metabolites in humans. Steroids 1998;63:401-5.
10. Stewart PM, Krozowski ZS. 11β-hydroxysteroid dehydrogenase. Vitam Horm 1999;57:249-324.
11. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P et al. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 1997;94:14924-9.
12. Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C et al. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 2002;45:1528-32.
13. Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11β-HSD2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension 2001;38:1330-6.
14. Dullaart RPF, Ubels FL, Hoogenberg K, Smit AJ, Pratt JJ, Muntinga JHJ et al. Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition. J Clin Endocrinol Metab 1995;80:3002-8.
15. Luik FF, Hoogenberg K, van der Kleij FGH, Beusekamp BJ, Kerstens MN, de Jong PE et al. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus. Diabetologia 2002;45:535-41.
16. Pratt JJ. Steroid immunoassay in clinical chemistry. Clin Chem 1978;24:1869-90.
17. Kerstens MN, Riemens SC, Sluiter WJ, Pratt JJ, Wolthers BG, Dullaart RPF. Lack of relationship between 11β-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24 h of insulin infusion in healthy subjects and type 2 diabetic patients. Clin Endocrinol 2000;52:403-11.
18. Wolthers BG, Kraan GP. Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids. J Chromatogr A 1999;843:247-74.
19. Palermo M, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol 1996;45:605-11.
20. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1997;82:151-5.
21. Kasuya Y, Shibasaki H, Furuta T. The use of deuterium-labeled cortisol for in vivo evaluation of renal 11β-HSD activity in man: urinary excretion of cortisol, cortisone and their A-ring reduced metabolites. Steroids 2000;65:89-97.
22. Zumoff B, Fukushima DK, Hellman L. Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab 1974;38:169-75.
23. Mericq MV, Cutler GB Jr. High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab 1998;83:682-4.
24. Kraan GP, Dullaart RPF, Pratt JJ, Wolthers BG, Drayer NM, de Bruin R. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 1998;83:1247-52.
25. Vierhapper H, Nowotny P, Waldhausl W. Sex-specific differences in cortisol production rates in humans. Metabolism 1998;47:974-6.
26. Livingstone DEW, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-3.
27. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DEW, Johnson O et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86:1418-21.
28. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 1995;80:3155-9.
29. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70.
30. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276:41293-300.
31. Andrews RC, Herlihy O, Livingstone DEW, Andrew R, Walker BR. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab 2002;87:5587-93.
32. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson DC. Effect of sodium intake on insulin sensitivity. Am J Physiol 1993;264:E730-E734.
33. Kerstens MN, van der Kleij FGH, Boonstra AH, Sluiter WJ, Koerts J, Navis G et al. Salt loading affects cortisol metabolism in normotensive subjects: relationships with salt-sensitivity. Eur J Clin Invest 2003;33 (Suppl. 1):39.